Exane Derivatives’s SL Green Realty SLG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$692 Buy
+15
New +$954 ﹤0.01% 539
2022
Q1
Sell
-16
Closed -$1.15K 1083
2021
Q4
$1.15K Hold
16
﹤0.01% 693
2021
Q3
$1.13K Hold
16
﹤0.01% 849
2021
Q2
$1.24K Hold
16
﹤0.01% 855
2021
Q1
$1.12K Sell
16
-1
-6% -$67 ﹤0.01% 722
2020
Q4
$1.01K Sell
17
-1
-6% -$53 ﹤0.01% 678
2020
Q3
$788 Hold
18
﹤0.01% 642
2020
Q2
$838 Sell
18
-2,467
-99% -$113K ﹤0.01% 565
2020
Q1
$104K Buy
2,485
+50
+2% +$3.9K 0.03% 277
2019
Q4
$214K Buy
2,435
+2,431
+60,775% +$200K 0.04% 254
2019
Q3
$327 Hold
4
﹤0.01% 612
2019
Q2
$321 Hold
4
﹤0.01% 618
2019
Q1
$360 Hold
4
﹤0.01% 556
2018
Q4
$316 Hold
4
﹤0.01% 621
2018
Q3
$388 Hold
4
﹤0.01% 583
2018
Q2
$409 Buy
+4
New +$378 ﹤0.01% 573
2017
Q4
Sell
-1
Closed -$101 635
2017
Q3
$101 Sell
1
-3
-75% -$291 ﹤0.01% 509
2017
Q2
$423 Buy
+4
New +$408 ﹤0.01% 503

Other funds holding SLG

Exane Derivatives's SLG Position: Q2 2022 in Review

Exane Derivatives opened a new position in SL Green Realty (SLG) in Q2 2022: 15 shares worth $692. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in SLG as recently as Q4 2021.

Exane Derivatives first reported a position in SLG in Q2 2017 and has held it in 18 quarters since. The position peaked at $214K in Q4 2019. 320 funds tracked by Wall St. Rank hold SLG as of Q2 2022.

  • Exane Derivatives held 15 shares of SL Green Realty worth $692 as of Q2 2022.
  • SL Green Realty was a new Exane Derivatives position in Q2 2022.
  • SL Green Realty made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #539 holding.
  • Exane Derivatives first reported a position in SL Green Realty in Q2 2017 and has held it in 18 quarters since.
  • Exane Derivatives's SL Green Realty position peaked at $214K in Q4 2019.
  • 320 funds tracked by Wall St. Rank held SL Green Realty as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.